COVID-19: Vaccines and Therapeutics

The FDA and CDC鈥檚 recent booster shot policy decisions are important steps toward ending COVID-19. The FDA and CDC鈥檚 review further confirms the safety and efficacy of the COVID-19 vaccines, and underscores why hospitals and health systems have worked so hard to vaccinate their staff and鈥
In a study of more than 4,900 health care workers across 33 sites in 25 U.S. states, the Pfizer and Moderna COVID-19 vaccines were 89% and 96% effective, respectively, at preventing symptomatic COVID-19 infections in fully vaccinated workers, according to final results reported yesterday in the New鈥
In AHA鈥檚 newest #MyWhy video, nine hospital employees from UAB Medicine in Alabama candidly discuss their COVID-19 vaccine experience, starting with initial hesitancies and navigating misinformation surrounding the vaccine鈥檚 development and rumored side effects.
The Centers for Medicare & Medicaid Services yesterday began publicly sharing COVID-19 vaccination rates for nursing home staff and residents on its Care Compare website. 
Johnson & Johnson said its phase 3 trial data confirms its vaccine鈥檚 durability and provided evidence of a second, booster shot鈥檚 effectiveness against COVID-19.
The Food and Drug Administration authorized administering the monoclonal antibodies bamlanivimab and etesevimab together to prevent COVID-19 in certain children and adults exposed to SARS-CoV-2 who are not fully vaccinated against COVID-19 and at high-risk for progressing to severe disease. 
Pfizer released the first data evaluating a COVID-19 vaccine鈥檚 safety and effectiveness for children between the ages of 5 and 11.
The Food and Drug Administration鈥檚 Vaccines and Related Biological Products Advisory Committee by a unanimous vote recommended that the FDA issue an emergency use authorization that would enable COVID-19 vaccine boosters for individuals age 65 and older and those at high risk for severe COVID-19,鈥
As COVID-19 care demands 鈥渙utstrip resources鈥 at some Idaho hospitals, health care leaders came together to discuss how they are addressing the crisis and reiterate the solution: vaccination.